Story preview
Continue reading on the publisher site for the full article.
Read on publisher →AD HOC NEWS
News Atlas is free and independent. If it’s useful to you, you can support it with a coffee. ☕ Buy me a coffee
Coverage
Tone
Context from Wikipedia on the organisations, people and places in this story.
Danish pharmaceutical company
Novo is a Danish multinational pharmaceutical company. Novo manufactures and markets pharmaceutical products and services, primarily diabetes and obesity medications and devices. The corporation was created in 1989, through a merger of two Danish pharmaceutical companies, which date back to the 1920s.
More on Wikipedia ↗Outlets covering it
3
in the last 3 days
First reported
3 days ago
2 outlets since
Countries
2 other outlets reported this story in the last 3 days.
Novo Nordisk stock costs EUR 34.56 on October 12, 2026. The NYSE quote was USD 38.64 against a USD 3
Bristol Myers Squibb trades at a steeper discount despite higher leverage, while Novo Nordisk commands a premium on exceptional profitability and GLP-1 dominance.